Newsroom
Our latest developments
Orca Bio’s announcements and press releases
Orca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S.
ViewOrca Bio to Present New Clinical Data on Orca-T at the European Hematology Association 2022 Congress
ViewOrca Bio Presents Positive Data Reinforcing Clinical Profile and Manufacturing Reliability of Orca-T at 2022 Transplantation & Cellular Therapy ASTCT and CIBMTR Tandem Meetings
ViewOrca Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
ViewPositive Clinical Results from More than 100 Patients Treated with Orca Bio’s Lead Investigational High Precision Cell Therapy Presented at 63rd ASH Annual Meeting
ViewOrca Bio to Present New Clinical Data on Orca-T at the 63rd American Society of Hematology Annual Meeting
ViewOrca Bio Announces Updated Orca-T Clinical Data Presented at the 2021 TCT (Transplantation & Cellular Therapy) Meetings of the American Society of Transplantation and Cellular Therapy (ASTCT) and Center for International Blood & Marrow Transplant Research (CIBMTR)
View